Letters
More financial resources must be provided for multidrug resistant TB
BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7190.1076a (Published 17 April 1999) Cite this as: BMJ 1999;318:1076
- Matthias L Schmid, Specialist registrar in infectious diseases (Matthias.Schmid@csuh-tr.trent.nhs.uk),
- Michael W McKendrick, Consultant physician,
- Stephen T Green, Consultant physician,
- Elisabeth J Ridgway, Consultant microbiologist
- North Trent Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield S10 2JF
- Department of Microbiology, Royal Hallamshire Hospital
EDITOR—Drobniewski endorsed the need for the rational use of rapid diagnostic tools in the diagnosis of multidrug resistant tuberculosis.1 This model of rapid culture and sensitivity testing should become the rule rather than being the exception as at present. Only by making the earliest possible diagnosis can we achieve optimum management.
In England and Wales in 1997 there were 5859 notifications of tuberculosis and 447 deaths from the disease; isolates of multidrug resistant tuberculosis reported to the Communicable …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.